Sign In
Buy ABT
$93.24
+2.73 (+3.02%)
At Close: Jun 25, 2026
CoreCap Advisors LLC Boosts Stake in Abbott Laboratories $ABT
04:52am, Thursday, 08'th Jan 2026
CoreCap Advisors LLC increased its position in shares of Abbott Laboratories (NYSE: ABT) by 15.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commiss
Absolute Software Co. (ABT.TO) (TSE:ABT) Shares Cross Above 200 Day Moving Average – Should You Sell?
03:54am, Thursday, 08'th Jan 2026
Absolute Software Co. (ABT.TO) (TSE: ABT - Get Free Report)'s stock price passed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of C$0.00 and trad
PBH or ABT: Which Is the Better Value Stock Right Now?
12:41pm, Wednesday, 07'th Jan 2026
Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Abbott (ABT). But which of these two stocks is more attractive to value inve
Abbott: Not Cheap, But Built To Compound In Uncertain Markets
09:17am, Wednesday, 07'th Jan 2026
Abbott Laboratories is a defensive, high-quality compounder with a premium valuation justified by recurring cash flow and strong medical device platforms. Medical Devices, especially Diabetes Care (Li
The two properties strengthen the Company's presence in Illinois, where it currently owns and manages three other properties. LAS VEGAS, NEVADA / ACCESS Newswire / January 7, 2026 / Sentinel Net Lease
DSM Capital Partners LLC Increases Position in Abbott Laboratories $ABT
07:10am, Wednesday, 07'th Jan 2026
DSM Capital Partners LLC increased its holdings in Abbott Laboratories (NYSE: ABT) by 7.8% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and
Cerity Partners LLC Sells 8,052 Shares of Abbott Laboratories $ABT
06:04am, Wednesday, 07'th Jan 2026
Cerity Partners LLC lowered its stake in shares of Abbott Laboratories (NYSE: ABT) by 0.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and
Abbott Laboratories $ABT Shares Sold by First Merchants Corp
05:32am, Wednesday, 07'th Jan 2026
First Merchants Corp lowered its position in shares of Abbott Laboratories (NYSE: ABT) by 9.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commi
PBH vs. ABT: Which Stock Is the Better Value Option?
12:41pm, Tuesday, 06'th Jan 2026
Investors looking for stocks in the Medical - Products sector might want to consider either Prestige Consumer Healthcare (PBH) or Abbott (ABT). But which of these two stocks offers value investors a b
Abbott (ABT) Rises Higher Than Market: Key Facts
07:00pm, Monday, 05'th Jan 2026
In the latest trading session, Abbott (ABT) closed at $126.45, marking a +1.82% move from the previous day.
Abbott hosts conference call for fourth-quarter earnings
04:30pm, Monday, 05'th Jan 2026
ABBOTT PARK, Ill., Jan. 5, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its fourth-quarter 2025 financial results on Thursday, Jan. 22, before the market opens.
Abbott's new Libre Assist app feature tackles a top need for people living with diabetes: in-the-moment food decisions
09:05am, Monday, 05'th Jan 2026
Traditional food logging apps offer feedback after the fact—Libre Assist1 offers help in-the-moment to inform mealtime decisions before every bite Libre Assist1 leverages AI to predict how food choi
Railway Pension Investments Ltd Reduces Stock Holdings in Abbott Laboratories $ABT
07:20am, Monday, 05'th Jan 2026
Railway Pension Investments Ltd decreased its position in Abbott Laboratories (NYSE: ABT) by 67.6% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchan
Abbott Laboratories $ABT Shares Acquired by Asset Management One Co. Ltd.
05:48am, Sunday, 04'th Jan 2026
Asset Management One Co. Ltd. raised its position in shares of Abbott Laboratories (NYSE: ABT) by 2.4% during the undefined quarter, according to its most recent disclosure with the Securities and Exc
Citadel Investment Advisory Inc. Lowers Holdings in Abbott Laboratories $ABT
04:31am, Sunday, 04'th Jan 2026
Citadel Investment Advisory Inc. reduced its position in shares of Abbott Laboratories (NYSE: ABT) by 89.9% during the undefined quarter, according to its most recent 13F filing with the Securities an
